← Open Payments lookup

EDWIN TORRES: Open Payments

NPI 1053715243 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,856 in 67 payments from 11 companies in 2025. Trend: 2023 $8,493 · 2024 $19,140 · 2025 $16,856

Consulting: $6,683Speaker / faculty: $6,275Food & beverage: $2,142Travel & lodging: $1,757
CompanyPaymentsAmount
Novo Nordisk Inc24$9,096
Boehringer Ingelheim Pharmaceuticals, Inc.14$5,368
Corcept Therapeutics9$1,208
Lilly USA, LLC2$704
Xeris Pharmaceuticals, Inc.6$235
AstraZeneca Pharmaceuticals LP6$112
Novartis Pharmaceuticals Corporation2$45
Bayer Healthcare Pharmaceuticals Inc.1$23
Merck Sharp & Dohme LLC1$23
Insulet Corporation1$22

Products named: Ozempic, JARDIANCE, Korlym, RECORLEV, Rybelsus, FARXIGA, WAINUA, LEQVIO.

Industry payments across NY — which companies pay providers there.